Deals

Derma Sciences Raises $31M in CMPO

By |

Derma Sciences (DSCI) has raised $31.66 million in a CMPO/Overnight transaction. The common stock was sold at $10.34 per share, or a 0% premium to the market price of DSCI at deal announcement. Piper Jaffray acted as the lead agent with Oppenheimer and Canaccord Genuity acting as co-agents. Roth Capital Partners acted as financial advisor on the transaction. Placement Agent counsel was Goodwin Procter, and issuer counsel was Thompson & Hine. The transaction is expected to close by Dec.

Deals

Lazard, Roth Place Novabay Pharmaceuticals CMPO

By |

Novabay Pharmaceuticals (NBY) has raised $7.38 million in a CMPO/Overnight transaction. The common stock was sold at $1.25 per share, an approximate 10% discount to the market price ($1.39) of NBY at deal announcement. A series of 4,425,000 12-Month Warrants with an exercise price of $1.50 per share (7.91% premium) was issued to the investors. Lazard acted as Lead Agent with Roth Capital Partners acting as Co-Agent on the transaction. Placement Agent counsel was Proskauer Rose, and issuer counsel was Cooley.

Deals

Diagnostic Imaging International Issues Convertible Notes

By |

Diagnostic Imaging International Corp. (DIIG) has raised $1.87 million in a Convertible Notes transaction. The fixed conversion price of the Convertible Notes is $0.10 per share, an approximate 100% premium to the market price ($0.05) of DIIG at deal announcement. Issuer counsel was Golenbock Eiseman Assor Bell & Peskoe. The transaction closed on Dec. 5, 2012.

Deals

SAIL Capital Funds CNS Response

By |

CNS Response (CNSO) announced that it has raised $1.8 million in a Convertible Secured Promissory Notes transaction with investors including funds managed by SAIL Capital Partners and Equity Dynamics. The fixed conversion price of the Convertible Secured Promissory Notes is $0.0472 per share, an approximate 94.76% discount to the market price ($0.90) of CNSO at deal announcement. The transaction closed on Dec. 4, 2012. This Placement is part of a $2 million financing.